Impetigo herpetiformis successfully treated with brodalumab

J Dermatol. 2022 Apr;49(4):e149-e150. doi: 10.1111/1346-8138.16285. Epub 2021 Dec 27.

Authors

Yumi Nakai¹, Himino Ashida¹, Ai Kajita¹, Emi Yokoyama¹, Kazumitsu Sugiura², Shin Morizane¹

Affiliations

¹ Department of Dermatology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
² Department of Dermatology, School of Medicine, Fujita Health University, Aichi, Japan.

PMID: 34958497
DOI: 10.1111/1346-8138.16285

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Dermatitis Herpetiformis* / diagnosis
Dermatitis Herpetiformis* / drug therapy
Humans
Impetigo* / diagnosis
Impetigo* / drug therapy
Pregnancy Complications*
Psoriasis*
Skin Diseases, Vesiculobullous*

Substances

Antibodies, Monoclonal, Humanized
brodalumab